To The Moon

Meta up as Trump invests $25m. Investors, before you follow Trump's investment strategies,  think about what proportion of his wealth that $25m is. Also, his strategy seems to be to buy a stock, announce his investment and wait for it to climb. Then he sells. It's a zero sum game. He wins because you lose. It's a glorified Pump & Dump scheme and I'm baffled that investors are falling for this...repeatedly. 

It is clear that nobody...absolutely nobody listens to Trump. https://www.nzherald.co.nz/world/russia-hits-ukraine-power-plants-after-trumps-energy-ceasefire-claim/DR7NFWEANBAPNLK42MRQIRLB6U/

Shut up you Orange Idiot. You didnt get a prize because you are an arrogant and ignorant fool who starts wars.

Oh Shut up, Trump. Nobody believes a word you say. Bribery will not get you throgh this. You ARE going down, buddy.

Oh shut up Trump. How many times have you sang  this song before??  Iran is laughing at you.

Translation: Trump is ready to sell his stocks and wants the price to rise before he does. Do not believe a word of it.

The news — A repeat of the July 24 disclosure about the SEC subpoena and the Hagens Berman investigation — was simply republished, not updated with new facts. Investor reaction — Many retail investors (and some algorithmic traders) respond to headline cues without verifying the publication date or novelty of the information. Effect — Selling pressure snowballs because short-term traders see red on the chart and join the move, often creating a larger drop than is rational from a valuation standpoint. Core business — No new data suggests a change to Telix’s earnings outlook, pipeline progress, or valuation metrics. Analyst price targets remain well above the current share price. It’s the same behavioral quirk that fuels “dead cat bounces” and “overreaction gaps” — when traders overreact to a

Simply Wall Street rehashes an old article from 24 July and investors sell off. Investor behaviour can be so irrational at times, you just gotta laugh. :)

Oh shut up Muskeeto.

Telix (TLX.AX) – What Just Happened? A Quick Summary for Investors A couple of seemingly conflicting reports have dropped this week regarding Telix Pharmaceuticals, so here’s a plain-English breakdown of what’s going on, what it might mean, and where things could go from here. 🧾 The News Morningstar Cuts EBIT Forecasts (6 Aug – Reuters) Morningstar reduced its EBIT (earnings before interest and taxes) forecasts for Telix by an average of 29% over the next two years. Reason: Delays in cost efficiencies from Telix’s recent US acquisition of RLS Radiopharmacies. Operating Expenses (OPEX) for H1 FY25 are now forecast at 36% of revenue, up from 28% last year (though some investor analysis suggests last year’s figure was closer to 93%, raising questions). Despite the lowered EBIT forecasts, Morn